While the news media can over state some news articles or interpret them in their own way, the Venlafaxine one has gathered momentum via the news media.

Pfizer have clearly advised that they are intending to stay in this market.

This was clearly demonstrated prior to the change of brands, when we supplied an analysis to enable pharmacy to discuss this change with the patient and advise them that they could stay on their existing Efexor-XR for a small monthly fee.

Click here to read the analysis.

Please note this is based on an NSS mark up of 20% for the purpose of the analysis only. We cannot and will not advise pharmacy on what mark-up they should apply. That is up to each individual.

In saying that you must be fully aware of the current market activities and the fact that we have Zoom & Chemist Warehouse all undertaking to provided NSS prescription items at the lowest price to patient. Patients can have their scripts dispensed from outside their home town. Make sure you do not simply allow this market to grow at your cost.

We thank you in anticipation of your ongoing support.

Should you wish to discuss this matter please do not hesitate to contact you Sales Manager or Key Account Manager.

About The Author